Haemonetics Corporation
HAE | NYSE
$121.14
+$1.49 (+1.25%)
Nov 2, 2026, 10:30 AM ET · Market open
Market Data
Market Cap $5.51B
Enterprise Value $6.39B
Beta 0.54
Average Volume 711.63K
Shares Outstanding (Diluted) 45.7M
Shares Change YoY -5.48%
Institutional Ownership N/A
Exchange NYSE
ISIN US4050241003
Price Performance
Price Change 1M 15.7%
Price Change 3M 39.6%
Price Change 6M 119.0%
Price Change YTD 51.1%
Price Change 1Y 141.0%
Price Change 3Y 37.0%
Price Change 5Y 65.3%
1M CAGR (ann.) 10.4%
1Y CAGR (ann.) 142.0%
5Y CAGR (ann.) 10.8%
All-Time CAGR 13.3%
Valuation
PE Ratio 58.65
Forward PE 21.56
PEG Ratio -1.55
Forward PEG 7.77
PS Ratio 4.03
Forward PS 3.80
PB Ratio 6.50
P/FCF Ratio 18.69
P/Adj. FCF Ratio 21.15
P/OCF Ratio 16.55
EV/Sales 4.73
EV/EBIT 42.31
EV/EBITDA 24.48
EV/FCF 21.96
Earnings Yield 1.7%
FCF Yield 5.3%
Adj. FCF Yield 4.7%
Financial Health
Net Debt $950.77M
Total Debt $1.17B
Cash & Short-Term Investments $223.38M
Total Assets $2.37B
Current Ratio 3.08
Quick Ratio 1.91
Debt / Equity Ratio 1.40
Debt / EBITDA 4.50
Debt / FCF 4.03
OCF / Debt 0.28
Interest Coverage 8.03
Altman Z-Score 3.38
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 57.4%
Operating Profit Margin 18.2%
EBITDA Margin 19.3%
Net Profit Margin 7.1%
FCF Margin 21.5%
Adj. FCF Margin 19.0%
SBC / Revenue 2.5%
SBC Impact (per share) -11.6%
Returns
Return on Assets 4.1%
Return on Equity 11.3%
Return on Invested Capital 8.6%
Return on Capital Employed 11.7%
Return on Tangible Assets 7.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 3.5%
Revenue CAGR 5Y 8.4%
Revenue CAGR 10Y 4.1%
EPS CAGR 3Y -8.3%
EPS CAGR 5Y 10.3%
EPS CAGR 10Y 17.6%
FCF CAGR 3Y 18.3%
FCF CAGR 5Y 41.1%
FCF CAGR 10Y 21.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 47.8%
Revenue Growth Next 3Y 6.2%
Earnings Date Nov 5, 2026
EPS Estimate (next Q) $1.29
EPS Growth Est (next Q) 1.6%
Revenue Est (next Q) $345.15M
Revenue Growth Est (next Q) 5.5%
Fair Value Estimates
Graham Number $29.10
Graham Upside -75.7%
Lynch Fair Value $20.99
Lynch Upside -82.5%
Price Target $130.80
Price Target Upside 9.3%
Cash Flow
Operating Cash Flow $328.15M
Free Cash Flow $291.22M
Adj. Free Cash Flow $257.39M
FCF Per Share $6.42
OCF Per Share $7.23
OCF/S Ratio 24.3%
Income Statement
Revenue $1.35B
Gross Profit $775.84M
Operating Income $245.74M
EBITDA $261.21M
Net Income $96.29M
EPS (Diluted) $2.04
Revenue / Employee $449.32K
Profit / Employee $32K
Employees 3,009
Add to Watchlist
Select watchlists to add or remove HAE